| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0006 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |